Dentium (145720) Q2 2026 earnings summary

Executive summary

• Revenue grew 9% year-over-year to 89.3 billion KRW, driven by strong overseas sales, especially in China and Russia.

• Operating profit decreased 5% year-over-year to 14.7 billion KRW due to increased one-time provisions.

• Net income surged 193% year-over-year to 13.9 billion KRW, supported by foreign exchange gains.

• Specializes in dental implants and dental medical devices, with a strong export focus (80% of sales overseas).

• Diversifying into hydrogen fuel cell energy business, leveraging zirconia material expertise.

Financial highlights

• EBITDA reached 21.9 billion KRW, up slightly from 21.5 billion KRW in the same quarter last year.

• Gross margin was 64.8%, down 1 percentage point year-over-year.

• Operating margin was 16.4%, down from 18.9% year-over-year.

• H1 2026 consolidated revenue: KRW 160.7 billion; net income: KRW 30.9 billion.

• Cash and cash equivalents at period end: KRW 62.4 billion.

Outlook and guidance

• Anticipates continued sales growth in China with the implementation of VBP 2.0 in the second half.

• Expects sustained strong demand in Russia and gradual recovery in domestic implant demand from Q4.

• Hydrogen fuel cell business (SOFC) expected to begin sales after 2026, with new production facility in Vietnam.

• Dental segment continues to focus on digital solutions and global expansion, especially in China and emerging markets.